Human IgG-SAP serves as a control for the human IgG-containing immunolesioning agents. Conjugates utilizing human or humanized antibodies will benefit from using Human IgG-SAP as it is manufactured in an identical manner as other targeted conjugates, to give a definitive baseline for comparison.
Human IgG-SAP serves as a control for human IgG-containing immunolesioning agents.